“Incidence of central nervous system metastases in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with trastuzumab: A meta-analysis” (2021) Clinics, 76, p. e2653. doi:10.6061/clinics/2021/e2653.